QA: Paratek Pharmaceuticals Inc in us_pharma/2012

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001178711_2013_Paratek_Pharmaceuticals_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001178711, Paratek Pharmaceuticals Inc

  xvar xval
0 AssetsCurrent 94,966,000
1 IntangibleAssetsNetIncludingGoodwill 2,962,000
2 PropertyPlantAndEquipmentNet 128,000
3 remainder_Assets 0
4 LiabilitiesCurrent 2,663,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 10,263,000
9 ResearchAndDevelopmentExpense 11,191,000
10 remainder_Expenses 0
11 remainder_Revenues 9,597,000
12 remainder_NetIncome -159,000
13 remainder_ComprehensiveNetIncome -22,000
  yvar yval
0 Assets 98,056,000
1 Liabilities 2,663,000
2 Expenses 21,454,000
3 Revenues 9,597,000
4 StockholdersEquity 95,393,000
5 NetIncome -12,016,000
6 ComprehensiveNetIncome -12,027,000
7 BaseVar 65,975,500
8 EconomicCapitalRatiobeforeLimitedLiability 3.89
9 EconomicCapitalRatio 4.31

Edgar->Model Mapping

Feature Distribution

Change over Time